Morgan Stanley’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50,986
Closed -$299K 8136
2023
Q4
$299K Buy
50,986
+46,584
+1,058% +$551K ﹤0.01% 5794
2023
Q3
$112K Sell
4,402
-3,665
-45% -$301K ﹤0.01% 5846
2023
Q2
$1.12M Sell
8,067
-596
-7% -$76.5K ﹤0.01% 4767
2023
Q1
$788K Sell
8,663
-42,164
-83% -$5.72M ﹤0.01% 4996
2022
Q4
$6.96M Buy
50,827
+41,787
+462% +$14.1M ﹤0.01% 3441
2022
Q3
$7.84M Buy
9,040
+1,085
+14% +$680K ﹤0.01% 3222
2022
Q2
$3.48M Sell
7,955
-265
-3% -$138K ﹤0.01% 4085
2022
Q1
$5.22M Buy
8,220
+2,323
+39% +$1.46M ﹤0.01% 3644
2021
Q4
$5.25M Buy
5,897
+2,474
+72% +$2.6M ﹤0.01% 3667
2021
Q3
$4.34M Buy
3,423
+2,484
+265% +$3.01M ﹤0.01% 3890
2021
Q2
$1.14M Buy
939
+890
+1,816% +$1.2M ﹤0.01% 5007
2021
Q1
$65K Sell
49
-399
-89% -$565K ﹤0.01% 6230
2020
Q4
$601K Buy
448
+395
+745% +$452K ﹤0.01% 4965
2020
Q3
$55K Buy
+53
New +$55.4K ﹤0.01% 5694

Other funds holding CANO